SGMT
SGMT
NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$10.83
+0.98 (+9.95%)
As of Nov 14, 2:20 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 17 89%
Hold 1 5%
Sell 1 5%
Price Target
Analyst Price Target -72.3% upside
Low Target $2.20
Average Target $3.00
High Target $3.42
Current Price $10.83
Current
$10.83
Target
$3.00
$2.20 $3.00 avg $3.42
Scenario Analysis
Bear Case
$2.20
-79.7%
Low target
Base Case
$3.00
-72.3%
Avg target
Bull Case
$3.42
+-68.4%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$11.45
-5.4% from high
52-Week Low
$4.50
+140.7% from low
Target vs 52W High
$3.00
-73.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -33.8%